Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-60 of 2904 for cancer

Edit search filters
  1. Study Of ORIC-114 In Patients With Advanced Solid Tumors Harboring An EGFR Or HER2 Alteration

    Jacksonville, FL, Rochester, MN

  2. A Study Of SGN-CEACAM5C In Adults With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. Long-Term Safety Of Lutetium (177Lu) Vipivotide Tetraxetan In Participants With Prostate Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study Of JNJ-69086420, An Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (HK2) For Advanced Prostate Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Phase 1/2a Study Of IMM-1-104 In Participants With Previously Treated, RAS-Mutant, Advanced Or Metastatic Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. ADG126 In Combination With Pembrolizumab In Patients With Advanced/Metastatic Solid Tumors

    Jacksonville, FL, Rochester, MN

  7. A Phase 1 Study Of XL309 (ISM3091) Alone And In Combination In Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. CATALINA-4: A Study To Investigate The Safety And Efficacy Of TORL-1-23 With Chemotherapy Given Before Initial Surgery In Women With Advanced Stage Ovarian Cancer

    Rochester, MN

  9. A Clinical Study To Test If An Investigational Treatment Called BNT326 Is Safe And Potentially Beneficial When Used Alone Or In Combination With Other Investigational Treatments Such As BNT327, For People With Advanced Malignant Tumors

    Scottsdale/Phoenix, AZ

  10. Study Of DF9001 In Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer